GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » 6-1 Month Momentum %

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) 6-1 Month Momentum % : -27.78% (As of May. 08, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-08), Cannabis Bioscience International Holdings's 6-1 Month Momentum % is -27.78%.

The industry rank for Cannabis Bioscience International Holdings's 6-1 Month Momentum % or its related term are showing as below:

CBIH's 6-1 Month Momentum % is ranked worse than
85.46% of 1107 companies
in the Drug Manufacturers industry
Industry Median: 1.46 vs CBIH: -27.78

Competitive Comparison of Cannabis Bioscience International Holdings's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's 6-1 Month Momentum % falls into.



Cannabis Bioscience International Holdings  (OTCPK:CBIH) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Cannabis Bioscience International Holdings 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Headlines